| Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, RP Hasserjian, SM Devlin, H Tuechler, ... Nature medicine 26 (10), 1549-1556, 2020 | 458 | 2020 |
| Cancer therapy shapes the fitness landscape of clonal hematopoiesis KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ... Nature genetics 52 (11), 1219-1226, 2020 | 435 | 2020 |
| Molecular international prognostic scoring system for myelodysplastic syndromes E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JE Arango Ossa, ... NEJM evidence 1 (7), EVIDoa2200008, 2022 | 396 | 2022 |
| 3D ultrafast ultrasound imaging in vivo J Provost, C Papadacci, JE Arango, M Imbault, M Fink, JL Gennisson, ... Physics in Medicine & Biology 59 (19), L1, 2014 | 352 | 2014 |
| Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis T Gao, R Ptashkin, KL Bolton, M Sirenko, C Fong, B Spitzer, ... Nature communications 12 (1), 338, 2021 | 79 | 2021 |
| Unified classification and risk-stratification in acute myeloid leukemia Y Tazi, JE Arango-Ossa, Y Zhou, E Bernard, I Thomas, A Gilkes, ... Nature Communications 13 (1), 1-16, 2022 | 76 | 2022 |
| A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia J Mascarenhas, HE Kosiorek, JT Prchal, A Rambaldi, D Berenzon, ... Blood, The Journal of the American Society of Hematology 139 (19), 2931-2941, 2022 | 67 | 2022 |
| Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma V Yellapantula, M Hultcrantz, EH Rustad, E Wasserman, D Londono, ... Blood cancer journal 9 (12), 101, 2019 | 51 | 2019 |
| Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase JO Mascarenhas, RK Rampal, HE Kosiorek, R Bhave, E Hexner, ... Blood advances 4 (20), 5246-5256, 2020 | 50 | 2020 |
| Accelerated single cell seeding in relapsed multiple myeloma HJ Landau, V Yellapantula, BT Diamond, EH Rustad, KH Maclachlan, ... Nature communications 11 (1), 3617, 2020 | 43 | 2020 |
| Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers N Shukla, MF Levine, G Gundem, D Domenico, B Spitzer, N Bouvier, ... Nature communications 13 (1), 2485, 2022 | 29 | 2022 |
| Sistema para rehabilitacion del sindrome del miembro fantasma utilizando interfaz cerebro-computador y realidad aumentada JE Arango, JC Mazo, A PeñaPalacio Revista Ibérica de Sistemas e Tecnologias de Informação, 93, 2013 | 29 | 2013 |
| Isabl Platform, a digital biobank for processing multimodal patient data JS Medina-Martínez, JE Arango-Ossa, MF Levine, Y Zhou, G Gundem, ... BMC bioinformatics 21, 1-18, 2020 | 27 | 2020 |
| TP53 state dictates genome stability, clinical presentation and outcomes in myelodysplastic syndromes E Bernard, Y Nannya, T Yoshizato, RP Hasserjian, R Saiki, Y Shiozawa, ... Blood 134, 675, 2019 | 23 | 2019 |
| Transient expansion of TP53 mutated clones in polycythemia vera patients treated with idasanutlin BK Marcellino, N Farnoud, B Cassinat, M Lu, E Verger, E McGovern, ... Blood advances 4 (22), 5735-5744, 2020 | 21 | 2020 |
| Oncologic therapy shapes the fitness landscape of clonal hematopoiesis KL Bolton, RN Ptashkin, T Gao, L Braunstein, SM Devlin, D Kelly, M Patel, ... BioRxiv, 848739, 2019 | 21 | 2019 |
| Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures B Diamond, B Ziccheddu, K Maclachlan, J Taylor, E Boyle, JA Ossa, ... Blood, The Journal of the American Society of Hematology 141 (19), 2359-2371, 2023 | 17 | 2023 |
| Treatment of myelofibrosis patients with the TGF-β 1/3 inhibitor AVID200 (MPN-RC 118) induces a profound effect on platelet production J Mascarenhas, HE Kosiorek, R Bhave, JM Palmer, AT Kuykendall, ... Blood 138, 142, 2021 | 13 | 2021 |
| Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid; 2022 E Bernard, H Tuechler, PL Greenberg, RP Hasserjian, JEA Ossa, ... | 12 | |
| Landscape of TP53 mutations in MPN N Farnoud, C Famulare, E Papaemmanuil, E McGovern, J Medina, ... Blood 134, 1681, 2019 | 9 | 2019 |
Juan S. Medina-MartínezIsabl Inc.Verified email at isabl.io
